| CASE REPORT |
|
| Year : 2020 | Volume
: 13
| Issue : 2 | Page : 92-94 |
|
|
Secondary ocular hypertension post intravitreal dexamethasone implant (OZURDEX) managed by pars plana implant removal along with trabeculectomy in a young patient
Rathini Lilian David1, Parveen Sen2
1 Department of Glaucoma, Jadhavbhai Nathamal Singhvi, Sankara Nethralaya, Chennai, Tamil Nadu, India
2 Department of Vitreoretina, Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, Tamil Nadu, India
Correspondence Address:
Rathini Lilian David
Department of Glaucoma, Jadhavbhai Nathamal Singhvi, Sankara Nethralaya, No. 18, College Road, Nungambakkam, Chennai - 600 006, Tamil Nadu
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ojo.OJO_40_2018
|
|
|
We report a case of refractory secondary ocular hypertension after insertion of dexamethasone implant (OZURDEX) for posterior uveitis in a young patient, which necessitated removal of the implant through pars plana vitrectomy along with a trabeculectomy. A young male developed secondary ocular hypertension following dexamethasone implant (OZURDEX) injection for control of posterior uveitis. As the implant was still present in the vitreous cavity, we successfully performed a pars plana removal of the implant along with trabeculectomy with mitomycin C. Early intervention is essential to prevent glaucomatous optic neuropathy in young uveitic patients receiving OZURDEX implant.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
